National numbers, September 24

The COVID-19 plateau that I’ve described over the last couple of weeks continues, with wastewater and test positivity data showing that viral spread has slowed in much of the U.S. However, this is likely just a lull before respiratory virus season starts in earnest.

Read More

COVID source callout: You can’t search for COVID-19 information on Threads

Threads, the new text-based social media platform from Meta (the parent company of Facebook and Instagram), has blocked users from searching about COVID-19 or Long COVID. The block is a harmful choice by Meta, which will make it difficult for health experts, people with Long COVID, and other seeking information to find each other on this platform.

Read More

New COVID-19 vaccines are now available: 10 key facts and statistics about these shots

We now have two new COVID-19 vaccines available for this year’s respiratory virus season, one from Pfizer and one from Moderna, which are expected to perform well against current variants. The FDA approved both vaccines this week, and the CDC recommended them for almost all Americans.  A third option, from Novavax, may become available in the coming weeks as well.

Read More

National numbers, September 17

For the second week in a row, available data suggest that the current COVID-19 surge may be turning around, or at least heading for a plateau. But there’s still a lot of coronavirus going around—and this will likely remain true through the winter respiratory virus season.

Read More